Formation of 15alpha-hydroxyestriol and 15alpha-hydroxyestradiol from C19 15alpha-hydroxylated precursors in human pregnancy.
A mixture of 3H-15alpha-hydroxyandrostenedione and 14C-15alpha-hydroxydehydroisoandrosterone was injected intravenously into two subjects in the third trimester of pregnancy and, in a second study, directly into two fetuses in utero during transfusion for erythroblastosis fetalis. The urine was collected for 4-5 days and steroid conjugates in the urine were hydrolyzed into sulfate and glucosiduronate fractions. From the glucosiduronate fraction 15alpha-hydroxyestriol, 15alpha-hydroxyestradiol, 15alpha-hydroxyandrostenedione and 15alpha-hydroxydehydroisoandrosterone were isolated. No metabolites were identified in the sulfate fraction of the urine. A marked difference was observed in the metabolism of 15alpha-hydroxyandrostenedione and 15alpha-hydroxydehydroisoandrosterone which is dependent on the route of administration of the substrates. Both substrates were converted to 15alpha-hydroxyestriol and 15alpha-hydroxyestradiol, and the 3H/14C ratios and percentage conversions suggest that 15alpha-hydroxyandrostenedione seems to be a better precursor of the urinary 15alpha-hydroxylated estrogens than 15alpha-hydroxydehydroisoandrosterone. The 3H/14C ratios also suggest that 15alpha-hydroxydehydroisoandrosterone was converted to 15alpha-hydroxyestriol via 15alpha-hydroxyandrostenedione, and that the formation of 15alpha-hydroxyestradiol from 15alpha-hydroxydehydroisoandrosterone via 15alpha-hydroxyandrostenedione is a pathway of minor importance. Finally, 15alpha-hydroxydehydroisoandrosterone was recovered from the urine only when the precursors were injected into the maternal circulation. Also, an unknown metabolite containing only 14C was detected in the glucosiduronate fraction of the urine of each subject.
D000735:Androstenedione / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism; D001805:Blood Transfusion, Intrauterine; D003687:Dehydroepiandrosterone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism; D004899:Erythroblastosis, Fetal / Q000652:urine; D004958:Estradiol / Q000031:analogs & derivatives* / Q000652:urine; D004964:Estriol / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D006801:Humans; D006914:Hydroxysteroids / Q000008:administration & dosage / Q000378:metabolism / Q000652:urine; D007275:Injections, Intravenous; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011865:Radioisotope Dilution Technique
D006914:Hydroxysteroids; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D004958:Estradiol; D004964:Estriol